Home / TET2 Knockout Cell Lines

TET2 Knockout Cell Lines

Gene: TET2

Official Full Name: tet methylcytosine dioxygenase 2provided by HGNC

Gene Summary: The protein encoded by this gene is a methylcytosine dioxygenase that catalyzes the conversion of methylcytosine to 5-hydroxymethylcytosine. The encoded protein is involved in myelopoiesis, and defects in this gene have been associated with several myeloproliferative disorders. Two variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2011]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO00770 TET2 Knockout cell line (THP-1) Human TET2 1:2-1:4 Negative Online Inquiry
KO09676 TET2 Knockout cell line (HeLa) Human TET2 1:3~1:6 Negative Online Inquiry
KO09677 TET2 Knockout cell line (HCT 116) Human TET2 1:2~1:4 Negative Online Inquiry
KO09678 TET2 Knockout cell line (HEK293) Human TET2 1:3~1:6 Negative Online Inquiry
KO09679 TET2 Knockout cell line (A549) Human TET2 1:3~1:4 Negative Online Inquiry

Background

TET2 Gene Knockout Cell Lines are genetically modified cell lines in which the TET2 gene, responsible for regulating DNA methylation and epigenetic modifications, has been disrupted. This product serves as a critical tool for researchers investigating the biological roles of TET2 in cellular processes, particularly in hematopoiesis and various malignancies such as acute myeloid leukemia (AML).

The key function of TET2 involves its enzymatic activity in converting 5-methylcytosine to 5-hydroxymethylcytosine, thereby promoting an active demethylation process that influences gene expression and cellular differentiation. By using TET2 Gene Knockout Cell Lines, researchers can elucidate the consequences of TET2 loss on cell behavior, gene regulation, and cellular pathways linked to tumorigenesis. Furthermore, these cell lines facilitate the exploration of therapeutic strategies targeting TET2 mutations, allowing for the development of potential interventions in cancers where TET2 is a significant player.

The scientific importance of these knockout cell lines is underscored by their application in both basic and translational research. They enable detailed studies on the epigenetic landscape and provide valuable insights into the role of TET2 mutations in development and disease progression. In clinical settings, understanding how TET2 deficiencies contribute to disease can help in stratifying patients and tailoring personalized therapies.

Compared to alternatives such as transient knockdown systems, TET2 Gene Knockout Cell Lines offer stably expressed and highly reproducible models for long-term studies. The creation of stable knockout mutations can provide more consistent data, facilitating the identification of drug targets or biomarkers associated with TET2-related diseases.

For researchers and clinicians focused on epigenetics and hematologic cancers, TET2 Gene Knockout Cell Lines represent an invaluable resource. Their use can accelerate advancements in molecular biology and therapeutic development. Our company emphasizes a commitment to providing high-quality biological products, backed by extensive expertise in genetic engineering and cell line development, ensuring reliable tools for your research needs.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.